Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,933
The JULI Registry--Hemp and Cannabis Observational Registry
for
Chronic Pain, Appetite Disorders, Neuropathy,
Location: Dallas TX, Nashville TN, San Jose CA, Los Gatos CA
Sponsor: Juva Life
Sex: All
Age: 21+
Code: NCT04726254
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Dallas TX, Willow Park TX, Austin TX, The Woodlands TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase 2, Phase 3, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Dallas TX, Arlington TX, Fort Worth TX, Willow Park TX,
Sponsor: Amgen
Sex: All
Age: 50+
Code: NCT07614776
Phase 3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Dallas TX, Southlake TX, Tyler TX, Round Rock TX,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase 2, Recruiting
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Location: Dallas TX, Willow Park TX, Tyler TX, Austin TX,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT07064759
Phase 3, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
for
Retinitis Pigmentosa (RP), Usher Syndrome
Location: Dallas TX
Sponsor: Nacuity Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07710196
Phase 3, Recruiting
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
Location: Dallas TX, Aurora CO, Atlanta GA, Madison WI,
Sponsor: Splice Bio
Sex: All
Age: 12 - 65
Code: NCT06435000
Recruiting
Patch-free Occlusion Therapy
for
Amblyopia
Location: Dallas TX
Sponsor: Retina Foundation of the Southwest
Sex: All
Age: 3 - 12
Code: NCT05440448
Recruiting
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Dallas TX, Cincinnati OH, Phoenix AZ
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 6+
Code: NCT07734064
Phase 1, Recruiting
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Dallas TX, Southaven MS, Chicago IL, Cincinnati OH,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
for
Geographic Atrophy (GA)
Location: Dallas TX, Austin TX, The Woodlands TX, Lakewood CO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50+
Code: NCT07230834
Phase 1, Recruiting
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
for
Stargardt Disease
Location: Dallas TX, Bellaire TX, Rochester MN, Phoenix AZ,
Sponsor: AAVantgarde Bio Srl
Sex: All
Age: 8 - 55
Code: NCT07161544
Phase 1, Phase 2, Recruiting
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Dallas TX, Cincinnati OH, Los Angeles CA, New York NY